Nicotinamide Mononucleotide (NMN) Market 2025: Emerging Trends, Innovations, and Growth Forecast

LOS ANGELES, United States: The report named, "Nicotinamide Mononucleotide (NMN) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" has been added to the archive of market research studies by QY Research. The global Nicotinamide Mononucleotide (NMN) market is researched with great precision and in a comprehensive manner to help you identify hidden opportunities and become informed about unpredictable challenges in the industry. The authors of the report have brought to light crucial growth factors, restraints, and trends of the global Nicotinamide Mononucleotide (NMN) market. The research study offers complete analysis of critical aspects of the global Nicotinamide Mononucleotide (NMN) market, including competition, segmentation, geographical progress, manufacturing cost analysis, and price structure. We have provided CAGR, value, volume, sales, production, revenue, and other estimations for the global as well as regional markets. Companies are profiled keeping in view their gross margin, market share, production, areas served, recent developments, and more factors.

The global market for Nicotinamide Mononucleotide (NMN) was estimated to be worth US$ 418 million in 2024 and is forecast to a readjusted size of US$ 992 million by 2031 with a CAGR of 13.4% during the forecast period 2025-2031.

Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample/4697611

With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.

At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.

Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.

The segmental analysis includes deep evaluation of each and every segment of the global Nicotinamide Mononucleotide (NMN) market studied in the report. All of the segments of the global Nicotinamide Mononucleotide (NMN) market are analyzed on the basis of market share, revenue, market size, production, and future prospects. The regional study of the global Nicotinamide Mononucleotide (NMN) market explains how different regions and country-level markets are making developments. Furthermore, it gives a statistical representation of their progress during the course of the forecast period. Our analysts have used advanced primary and secondary research methodologies to compile the research study on the global Nicotinamide Mononucleotide (NMN) market.

Details of Nicotinamide Mononucleotide (NMN) Market Segmentation: -

Key Manufacturers Operating in the Global Nicotinamide Mononucleotide (NMN) Market are:

GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical

Segment by Type:

Content 98%
Content 98%

Segment by Application:

Health Care Products
Cosmetics
Others

The authors of the report have analyzed both developing and developed regions considered for the research and analysis of the global Nicotinamide Mononucleotide (NMN) market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Nicotinamide Mononucleotide (NMN) markets to help players plan effective expansion strategies. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Nicotinamide Mononucleotide (NMN) markets to extend their reach and create sales opportunities.

Report Objectives

(1) Thoroughly analyzing and forecasting the size of the global Nicotinamide Mononucleotide (NMN) market by value and volume

(2) Estimating the market shares of key segments of the global Nicotinamide Mononucleotide (NMN) market

(3) Showing the development of the global Nicotinamide Mononucleotide (NMN) market in different parts of the world

(4) Evaluating micro-markets in terms of their contributions to the global Nicotinamide Mononucleotide (NMN) market, their prospects, and individual growth trends

(5) Giving accurate and useful details about factors influencing the growth of the global Nicotinamide Mononucleotide (NMN) market

(6) Providing detailed assessment of important business strategies adopted by leading companies operating in the global Nicotinamide Mononucleotide (NMN) market, which include research and development, agreements, collaborations, partnerships, mergers, acquisitions, new developments, and product launches

With a view to estimate and verify the size of the global Nicotinamide Mononucleotide (NMN) market and various other calculations, our researchers took bottom-up and top-down approaches. They used secondary research to identify key players of the global Nicotinamide Mononucleotide (NMN) market. In order to collect key insights about the global Nicotinamide Mononucleotide (NMN) market, they interviewed marketing executives, directors, VPs, CEOs, and industry experts. They also gathered information and data from quarterly and annual financial reports of companies. The final qualitative and quantitative data was obtained after analyzing and verifying every parameter affecting the global Nicotinamide Mononucleotide (NMN) market and its segments. We used primary sources to verify all breakdowns, splits, and percentage shares after determining them with the help of secondary sources.

Our analysts arrived at accurate statistics of various segments and sub-segments of the global Nicotinamide Mononucleotide (NMN) market and completed the overall market engineering process with market breakdown and data triangulation procedures. We looked at trends from both the supply and demand sides of the global Nicotinamide Mononucleotide (NMN) market to triangulate the data.

For Further insights and Detailed Reports, Visit: https://www.qyresearch.com/customize/4697611

Table of Contents

1 Market Overview
1.1 Nicotinamide Mononucleotide (NMN) Product Introduction
1.2 Global Nicotinamide Mononucleotide (NMN) Market Size Forecast
1.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value (2020-2031)
1.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume (2020-2031)
1.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Price (2020-2031)
1.3 Nicotinamide Mononucleotide (NMN) Market Trends & Drivers
1.3.1 Nicotinamide Mononucleotide (NMN) Industry Trends
1.3.2 Nicotinamide Mononucleotide (NMN) Market Drivers & Opportunity
1.3.3 Nicotinamide Mononucleotide (NMN) Market Challenges
1.3.4 Nicotinamide Mononucleotide (NMN) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company
2.1 Global Nicotinamide Mononucleotide (NMN) Players Revenue Ranking (2024)
2.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2020-2025)
2.3 Global Nicotinamide Mononucleotide (NMN) Players Sales Volume Ranking (2024)
2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Company Players (2020-2025)
2.5 Global Nicotinamide Mononucleotide (NMN) Average Price by Company (2020-2025)
2.6 Key Manufacturers Nicotinamide Mononucleotide (NMN) Manufacturing Base and Headquarters
2.7 Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Nicotinamide Mononucleotide (NMN)
2.9 Nicotinamide Mononucleotide (NMN) Market Competitive Analysis
2.9.1 Nicotinamide Mononucleotide (NMN) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Nicotinamide Mononucleotide (NMN) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide (NMN) as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Content 98%
3.1.2 Content 98%
3.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type
3.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (2020-2031)
3.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Type (%) (2020-2031)
3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type
3.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (2020-2031)
3.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Type (%) (2020-2031)
3.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Type (2020-2031)

4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Health Care Products
4.1.2 Cosmetics
4.1.3 Others
4.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application
4.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (2020-2031)
4.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Value, by Application (%) (2020-2031)
4.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application
4.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (2020-2031)
4.3.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume, by Application (%) (2020-2031)
4.4 Global Nicotinamide Mononucleotide (NMN) Average Price by Application (2020-2031)

5 Segmentation by Region
5.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region
5.1.1 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2020-2025)
5.1.3 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (2026-2031)
5.1.4 Global Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), (2020-2031)
5.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region
5.2.1 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2020-2025)
5.2.3 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (2026-2031)
5.2.4 Global Nicotinamide Mononucleotide (NMN) Sales Volume by Region (%), (2020-2031)
5.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.4.2 North America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.5.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.6.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.7.2 South America Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
5.8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value and Sales Volume
6.2.1 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Nicotinamide Mononucleotide (NMN) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.3.2 United States Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.4.2 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.5.2 China Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.6.2 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.7.2 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.8.2 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Nicotinamide Mononucleotide (NMN) Sales Value, 2020-2031
6.9.2 India Nicotinamide Mononucleotide (NMN) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Nicotinamide Mononucleotide (NMN) Sales Value by Application, 2024 VS 2031

7 Company Profiles
7.1 GeneHarbor
7.1.1 GeneHarbor Company Information
7.1.2 GeneHarbor Introduction and Business Overview
7.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Offerings
7.1.5 GeneHarbor Recent Development
7.2 Herbalmax
7.2.1 Herbalmax Company Information
7.2.2 Herbalmax Introduction and Business Overview
7.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Product Offerings
7.2.5 Herbalmax Recent Development
7.3 Genex Formulas
7.3.1 Genex Formulas Company Information
7.3.2 Genex Formulas Introduction and Business Overview
7.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Offerings
7.3.5 Genex Formulas Recent Development
7.4 Mirailab Bioscience
7.4.1 Mirailab Bioscience Company Information
7.4.2 Mirailab Bioscience Introduction and Business Overview
7.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Offerings
7.4.5 Mirailab Bioscience Recent Development
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Company Information
7.5.2 Maac10 Formulas Introduction and Business Overview
7.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Offerings
7.5.5 Maac10 Formulas Recent Development
7.6 EffePharm
7.6.1 EffePharm Company Information
7.6.2 EffePharm Introduction and Business Overview
7.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Product Offerings
7.6.5 EffePharm Recent Development
7.7 Bontac
7.7.1 Bontac Company Information
7.7.2 Bontac Introduction and Business Overview
7.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bontac Nicotinamide Mononucleotide (NMN) Product Offerings
7.7.5 Bontac Recent Development
7.8 CELFULL
7.8.1 CELFULL Company Information
7.8.2 CELFULL Introduction and Business Overview
7.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Product Offerings
7.8.5 CELFULL Recent Development
7.9 Kingdomway
7.9.1 Kingdomway Company Information
7.9.2 Kingdomway Introduction and Business Overview
7.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Product Offerings
7.9.5 Kingdomway Recent Development
7.10 ABA Chemical
7.10.1 ABA Chemical Company Information
7.10.2 ABA Chemical Introduction and Business Overview
7.10.3 ABA Chemical Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 ABA Chemical Nicotinamide Mononucleotide (NMN) Product Offerings
7.10.5 ABA Chemical Recent Development

8 Industry Chain Analysis
8.1 Nicotinamide Mononucleotide (NMN) Industrial Chain
8.2 Nicotinamide Mononucleotide (NMN) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nicotinamide Mononucleotide (NMN) Sales Model
8.5.2 Sales Channel
8.5.3 Nicotinamide Mononucleotide (NMN) Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.in
Tel: +91-8149736330
Email- ankit@qyresearch.com

This release was published on openPR.